Skip to content
Lawsuit Help Desk

Lawsuit News Center

Is Your Breast Implant Safe?: A Must Read

Is Your Breast Implant Safe?: A Must Read

Is Your Breast Implant Safe?: A Must Read

Breast augmentation is one of the most common plastic surgery procedures worldwide. However, the safety of certain types of breast implants has come under scrutiny in recent years. Allergan, a global pharmaceutical company, has been at the center of this controversy due to its textured breast implants, which have been linked to a rare form of cancer known as Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This has led to numerous lawsuits and settlements, which we will explore in this article.

BIA-ALCL is not breast cancer. It is a type of non-Hodgkin's lymphoma, a cancer of the immune system. In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body. The exact cause of BIA-ALCL is not known, but it has been found more frequently in patients with textured implants than in patients with smooth-surfaced implants.

In 2011, the U.S. Food and Drug Administration (FDA) identified a possible association between breast implants and the development of BIA-ALCL. By 2019, the FDA requested that Allergan recall specific models of its textured breast implants from the market, citing an increased risk of BIA-ALCL. Allergan complied with the recall, but many women had already received these implants and faced an increased risk of developing BIA-ALCL.

Following the recall, numerous lawsuits were filed against Allergan by women who had been diagnosed with BIA-ALCL. These lawsuits claim that Allergan knew about the potential risks associated with its textured implants but failed to warn the medical community or the public.

One such lawsuit is the case of Jennifer Cook, who was diagnosed with BIA-ALCL in 2017. In her lawsuit, Cook alleges that Allergan failed to disclose the risks associated with its textured implants and continued to market them as safe. She had to undergo surgery to remove the implants and receive treatment for BIA-ALCL, which included chemotherapy and radiation.

In another case, Renee Cashen, who also developed BIA-ALCL after receiving Allergan implants, alleges that Allergan intentionally concealed the risks and misrepresented the safety of its products. Cashen had to undergo multiple surgeries, including a double mastectomy and reconstructive surgery.

These are just two of the many women who have filed lawsuits against Allergan. As of now, hundreds of lawsuits have been consolidated in a multi-district litigation (MDL) in the U.S. District Court for the District of New Jersey. The MDL is still in the early stages, and no settlements have been announced yet.

While no settlements have been announced in the Allergan breast implant lawsuits, if the court finds in favor of the plaintiffs, the settlements could be substantial. In previous cases involving faulty medical devices, companies have paid out millions, and sometimes billions, of dollars to resolve lawsuits.

The Allergan breast implant lawsuits are a stark reminder of the potential risks associated with medical devices. While breast implants can boost self-esteem and improve quality of life, they are not without risks. It is crucial for companies to fully disclose these risks so that patients can make informed decisions about their health.

If you or a loved one has been diagnosed with BIA-ALCL after receiving Allergan breast implants, it may be in your best interest to consult with an attorney. You may be entitled to compensation for medical bills, lost wages, pain and suffering, and more.

#breastimplants #Allergan #lawsuits #settlements #BIAALCL #medicaldevices #FDA #cancer #lymphoma #plasticsurgery #health #legal #compensation

Please note that the information in this article is for informational purposes only and does not constitute legal advice.

Read more here